One of the more notable deals was Vertex Pharmaceuticals ' acquisition of Crinetics Pharmaceuticals for $10 billion in cash ...

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other ...

AbCellera’s T-cell engager (TCE) platform has reeled in a second client this summer, with Vertex Pharmaceuticals ...

As Hollywood's appetite for short-form, mobile-first storytelling continues to evolve, a new festival is positioning itself at the center of that transformation. ATLANTA — Vertex Micro Fest has ...

WSW, NY, July 22nd, 2026, FinanceWireTen billion dollars. That is what Vertex Pharmaceuticals (Nasdaq: VRTX) agreed to pay ...

Biogen has found a successor to longtime legal chief Susan Alexander, tapping former Vertex Pharmaceuticals executive and ...

Vertex Pharmaceuticals is buying Crinetics Pharmaceuticals for $10 billion. AlzeCure signed an out-licensing and collaboration deal with QuantumCell worth more than $2.2 billion. Novartis agreed to ...

Vertex has secured a label expansion through the FDA's Commissioner’s National Priority Voucher (CNPV) program, which allows children as young as 2 years of age to receive the gene therapy Casgevy for ...

The FDA approved the expansion of Casgevy, which had previously been greenlit for patients 12 and up, into a younger pediatric population under the agency’s Commissioner’s National Priority Voucher ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

July 1 (Reuters) - The U.S. Food and Drug Administration approved expanded use of Vertex Pharmaceuticals' (VRTX.O), opens new tab gene therapy in children as young as two with inherited blood ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, ...